TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Pharma Nord ApS
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
772,834
|
674,759
|
622,042 |
| Earnings before taxes |
62,412
|
39,248
|
60,976 |
| Total assets |
643,641
|
644,151
|
632,763 |
| Current assets |
292,774
|
341,071
|
368,773 |
| Current liabilities |
314,518
|
302,271
|
277,003 |
| Equity capital |
227,621
|
242,167
|
259,085 |
| - share capital |
318
|
302
|
283 |
| Employees (average) |
150
|
150
|
150 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
35.4%
|
37.6%
|
40.9% |
| Turnover per employee |
5,152
|
4,498
|
4,147 |
| Profit as a percentage of turnover |
8.1%
|
5.8%
|
9.8% |
| Return on assets (ROA) | |||
| Current ratio |
93.1%
|
112.8%
|
133.1% |
| Return on equity (ROE) |
27.4%
|
16.2%
|
23.5% |
| Change turnover |
62,411
|
11,992
|
-43,518 |
| Change turnover % |
9%
|
2%
|
-7% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.